Human Subjects Research Ethics

Understanding Human Subjects Research Ethics

Human subjects research is a cornerstone of modern medicine, yet it carries profound ethical responsibilities. This course explores the key concepts that guide Institutional Review Boards (IRBs) in protecting participants while enabling scientific advancement.

1. Defining a Human Subject

A human subject is defined as a living individual from whom data are obtained through intervention, interaction, or identifiable private information. This definition excludes anonymized data or specimens that cannot be linked back to the individual. Recognizing who qualifies as a subject is the first step in applying ethical safeguards.

• Intervention: any physical procedure, drug administration, or device use.
• Interaction: interviews, surveys, or observation where the researcher directly engages the person.
• Identifiable Private Information: medical records, biological samples, or any data that can be traced to the individual.

2. IRB Review Categories

IRBs evaluate research protocols using three primary pathways: Exempt, Expedited, and Full Board review. The level of risk and the nature of the procedures determine the appropriate category.

2.1 Exempt Review

Research is exempt when it involves minimal risk and fits specific categories, such as analysis of existing, de‑identified specimens. For example, studying discarded pathological specimens without identifiers typically qualifies for exempt review because the risk to participants is negligible.

2.2 Expedited Review

Expedited review applies to studies that present no more than minimal risk but do not meet the strict criteria for exemption. Common examples include:

• Non‑invasive procedures like EEG recordings of healthy volunteers.
• Questionnaires or surveys about sensitive topics (e.g., sexual behavior) that do not place participants at greater than minimal risk.
• Studies involving collection of biological samples where the risk is low and the procedures are well‑defined.

These protocols are reviewed by a subset of IRB members with appropriate expertise, allowing a faster approval process while still ensuring protection.

2.3 Full Board Review

Full board review is required for research that presents more than minimal risk, involves vulnerable populations, or includes procedures that could cause significant physical or psychological harm. Historical abuses, such as the Willowbrook State School study—where mentally retarded children were intentionally infected with hepatitis—highlight why rigorous oversight is essential for high‑risk protocols.

3. Roles Within the IRB

An IRB typically consists of five members, each bringing a distinct perspective:

• Scientist/Researcher Member: Evaluates the scientific merit, methodological soundness, and safety of the protocol.
• Ethicist: Provides moral guidance without focusing on scientific details.
• Community Representative: Ensures public trust and reflects community values.
• Legal Advisor: Addresses regulatory compliance and legal implications.

The scientist/researcher member is primarily responsible for assessing whether the study’s design is scientifically valid and whether the risks are justified by the potential benefits.

4. Informed Consent Essentials

Informed consent is a fundamental element of ethical research. For studies involving more than minimal risk, the consent document must contain several key components:

• Purpose of the study and its duration.
• Procedures to be performed.
• Potential risks and benefits.
• Statement that participation is voluntary and participants may withdraw without penalty.

Details about the investigator’s personal qualifications are not required in the basic consent elements, though they may be included for transparency.

5. Practical Scenarios

5.1 EEG Study of Healthy Volunteers

Because EEG is a non‑invasive technique that poses minimal risk, the appropriate IRB pathway is expedited review. This allows the study to proceed efficiently while still ensuring participant safety.

5.2 Questionnaire on Sexual Behavior

Even though the topic is sensitive, the study typically involves minimal risk and does not meet exemption criteria. Therefore, an expedited review is the most suitable pathway.

5.3 Use of De‑identified Pathological Specimens

When specimens lack identifiers, the research is considered low‑risk and qualifies for exempt review. No additional consent is required from the original patients.

6. Protocol Amendments and Changes

Any modification to an approved protocol—such as adding a new co‑investigator—must be submitted to the IRB via a Protocol Change form. The IRB reviews these changes before granting final approval to ensure that the study remains ethically sound throughout its lifecycle.

7. Key Takeaways for Researchers

• Identify whether your participants meet the definition of a human subject.
• Determine the correct IRB review category based on risk level and study design.
• Understand the distinct roles of IRB members, especially the scientist/researcher’s responsibility.
• Include all required elements in informed consent, but omit unnecessary personal qualifications.
• Submit protocol amendments promptly to maintain compliance.

By mastering these concepts, researchers can design ethically robust studies that respect participant rights while advancing medical knowledge.